However, a subset of patients with SLC25A1 mutations have been identified with a less severe clinical presentation more representative of CMS, including fatigable muscle weakness and increased neuromuscular jitter [18,84,85,86,87]. Here, SLC25A1 is linked to congenital myasthenic syndrome.